Basis: Latest reported fiscal year. Source: stored company filings and market data; unavailable inputs remain N/A.
The quick ratio (acid-test) is N/A as of Tuesday, October 6, 2026.
QUICK RATIO (ACID-TEST)
N/A
Market Cap
$3.49M
Quick Ratio (Acid-Test)
1.10
TTM Avg
5.81
3Y Avg
5.76
5Y Avg
3.90
Market Cap
$3.49M
Quick Ratio (Acid-Test)
1.97
TTM Avg
1.45
3Y Avg
2.21
5Y Avg
4.94
Market Cap
$3.46M
Quick Ratio (Acid-Test)
0.08
TTM Avg
0.52
3Y Avg
0.43
5Y Avg
0.47
Market Cap
$3.32M
Quick Ratio (Acid-Test)
5.42
TTM Avg
3.49
3Y Avg
5.10
5Y Avg
6.32
Market Cap
$3.27M
Quick Ratio (Acid-Test)
2.44
TTM Avg
1.83
3Y Avg
3.14
5Y Avg
3.65
Market Cap
$3.25M
Quick Ratio (Acid-Test)
3.73
TTM Avg
3.25
3Y Avg
4.33
5Y Avg
4.33
| NAME | MARKET CAP | QUICK RATIO (ACID-TEST) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Eocene Ltd. (EOCN) | $3.52M | N/A | N/A | N/A | N/A |
| Nexalin Technology, Inc. (NXL)vs › | $3.49M | 1.10 | 5.81 | 5.76 | 3.90 |
| Mustang Bio, Inc. (MBIO)vs › | $3.49M | 1.97 | 1.45 | 2.21 | 4.94 |
| Moolec Science S.A. (MLEC)vs › | $3.46M | 0.08 | 0.52 | 0.43 | 0.47 |
| Evogene Ltd. (EVGN)vs › | $3.46M | 3.54 | 2.77 | 4.28 | 5.12 |
| Aethlon Medical, Inc. (AEMD)vs › | $3.32M | 5.42 | 3.49 | 5.10 | 6.32 |
| IceCure Medical Ltd (ICCM)vs › | $3.27M | 2.44 | 1.83 | 3.14 | 3.65 |
| Cadrenal Therapeutics, Inc. Common Stock (CVKD)vs › | $3.25M | 3.73 | 3.25 | 4.33 | 4.33 |
| MBody AI Ltd. (MBAI)vs › | $3.17M | 0.05 | 0.10 | 7.85 | 8.89 |
| Ernexa Therapeutics Inc. (ERNA)vs › | $3.89M | 2.01 | 0.91 | 1.26 | 1.78 |
Quick Ratio
N/A
Excludes inventory
Current Ratio
N/A
Includes inventory
Quick Ratio = (Current Assets − Inventory) / Current Liabilities
The quick ratio is a stricter liquidity measure that excludes inventory, showing the ability to meet short-term obligations with the most liquid assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
